Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford to lead international consortium to unlock potential of programmable nucleic acid drugs

A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded £8m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.

New survey launched to explore the acceptability of the Gonococcal Controlled Human Infection Model in UK men.

Researchers at the University of Oxford have launched a new mixed methods study to explore the acceptability of the Gonococcal Controlled Human Infection Model (GC-CHIM) in UK men.

Irene Roberts delivers Ham-Wasserman Lecture

Awards & Appointments Children's Health Haematology

Presented at the American Society of Hematology Annual Meeting, the award and lectureship recognises individuals from outside the United States who have made significant contributions to Haematology.

Oxford vaccinologist Teresa Lambe honoured with Irish Abroad award

A vaccine scientist from the University of Oxford recently received the prestigious Presidential Distinguished Service Award for the Irish Abroad for 2022, which recognises the contribution of members of the Irish diaspora.

Oxford Ebola vaccine manufactured and shipped in record time by SII

More than 40,000 doses of Oxford’s Ebola vaccine have been manufactured by SII (Serum Institute of India) in just 60 days and doses shipped to Uganda.

From running COVID-19 trials to researching respiratory diseases - Daniela Ferreira discusses her journey from Brazil to Oxford

Daniela Ferreira, Professor of Mucosal Immunity and Infection at the Oxford Vaccine Group, Department of Paediatrics, has so much enthusiasm for her work on respiratory infections and vaccinology, you would be very hard-pressed not to want her to succeed

Paediatric Neurorunners for SSNAP take on Oxford Half Marathon

Members of the Paediatric Neuroimaging Research Group at the University of Oxford (based at the Newborn Care Unit) decided to team up to support SSNAP (Support for Sick Newborns And their Parents). The team of four (Simon Marchant, Maz Aspbury, Luke Baxter and Marianne van der Vaart) signed up for the Oxford half marathon on 16th October 2022 to raise money for the charity through sponsorship. A couple of injuries meant that only two crossed the finish line, but they put in enough effort for the whole team!

MenACWY teenage meningitis vaccine programme drives herd immunity across all ages

Researchers from the University of Oxford have today reported findings from a large-scale study that examined the impact of the UK’s MenACWY vaccination programme on the carriage of meningitis bacteria in the throats of UK teenagers. They have demonstrated the impact of the vaccine in generating herd protection, also called herd immunity, that protects all age groups.

IDRM officially launched its Inaugural Symposium

IDRM hosted a full day of scientific talks and networking on the 4th of November at its Inaugural Symposium. The event was made possible by the generous donation of the J.W. Jenkinson Trust and the support from Nanostring, Sony, Integra, and Evox Therapeutics.

Exploring the role of muscles with video games at IF Oxford Science and Ideas Festival

The Rinaldi research group joined the IF Oxford Science and Ideas Festival to showcase research on muscle strength and neuromuscular diseases.

Oxford gets £122m funding for healthcare research

Awards & Appointments Research

Health and care research in Oxford is to receive £122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.

Paediatrics 50th Anniversary: From Little Steps to Giant Leaps

On Wednesday 21st September, the Department of Paediatrics invited friends, colleagues, and supporters of the department to celebrate its 50th Anniversary at the Mathematical Institute situated next to the Old Radcliffe Infirmary.

Vice-Chancellor’s Innovation & Engagement Awards

Winners - The Oxford COVID-19 Vaccine: a vaccine for the world

Celebrating Childhood Cancer Awareness Month

September is Childhood Cancer Awareness Month, where our Childhood Leukaemia research group have taken action to help raise awareness for this cause.

How do muscles make us strong? Find out at IF Oxford Science & Ideas Festival

Public Engagement

If you've ever wondered about the role of the muscle, come and meet us at IF Oxford - the Oxford science and ideas Festival on Saturday 8th & 15th October, when our researchers will be challenging members of the public to play our "Muscle Switch" game and exploring why strength differs between us.

It’s not just Covid: the triple threat that could overwhelm the NHS this winter - Andrew Pollard

COVID-19 Vaccinology

A severe flu outbreak or new coronavirus variant could prove catastrophic for a health service already on its knees

Study raises hope of pre-school type 1 diabetes screening programme

Children's Health Research

Researchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.

Oxford scientists honoured with eight Royal Society Awards

Each year, the Royal Society recognises exceptional research achievements through a series of prestigious medals and prizes named after great scientists of the past. Eight of the 2021-22 awards, announced today, honour Oxford University researchers for their outstanding contributions to science and medicine.

Promising Marburg vaccine yet to be tested on humans due to lack of funding

Oxford University’s Professor Teresa Lambe, the designer of the vaccine, fears Marburg disease is ‘now being seen in places where it’s never been seen before’

Oxford vaccine saved most lives in its first year of rollout

When the University of Oxford developed a vaccine that was effective against COVID-19, ensuring that it could be rolled out globally and in perpetuity for low- and middle-income countries was of paramount importance.

Load More